Maxime Guye Selected Research

Temporal Lobe Epilepsy

9/2008	Enhanced EEG functional connectivity in mesial temporal lobe epilepsy.
3/2006	Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex.
10/2002	Metabolic and electrophysiological alterations in subtypes of temporal lobe epilepsy: a combined proton magnetic resonance spectroscopic imaging and depth electrodes study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maxime Guye Research Topics

Disease

5	Epilepsy (Aura) 01/2021 - 02/2010
4	Multiple Sclerosis 10/2022 - 02/2014
4	Atrophy 01/2021 - 01/2017
4	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 08/2010
3	Neoplasms (Cancer) 02/2017 - 02/2010
3	Temporal Lobe Epilepsy 09/2008 - 10/2002
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 01/2018
2	Glioma (Gliomas) 02/2017 - 02/2015
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Drug Resistant Epilepsy 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Dementia (Dementias) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Sleep Deprivation 01/2018
1	Inflammation (Inflammations) 08/2017
1	Relapsing-Remitting Multiple Sclerosis 01/2017
1	Cognitive Dysfunction 01/2017
1	Sudden Unexpected Death in Epilepsy 01/2017
1	Disease Progression 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Apraxias (Dyspraxia) 01/2016
1	Paraganglioma (Paragangliomas) 08/2015
1	Idiopathic Generalized Epilepsy 08/2009
1	Periventricular Nodular Heterotopia 01/2008

Drug/Important Bio-Agent (IBA)

7	SodiumIBA 10/2022 - 02/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 09/2008
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
4	trans-sodium crocetinate (crocetin)IBA 01/2019 - 01/2017
2	Choline (Choline Chloride)IBA 02/2015 - 02/2010
2	N-acetylaspartate (N-acetyl aspartate)IBA 02/2015 - 02/2010
2	CreatineIBA 02/2015 - 02/2010
1	Memantine (Namenda)FDA Link 01/2018
1	Donepezil (Aricept)FDA LinkGeneric 01/2018
1	GadoliniumIBA 02/2017
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2016
1	ferric oxide (iron oxide)IBA 01/2016
1	Tricarboxylic AcidsIBA 08/2015
1	Succinic Acid (Succinate)IBA 08/2015
1	Oxygen (Dioxygen)IBA 08/2010
1	Immunoglobulin E (IgE)IBA 08/2009
1	Complement System Proteins (Complement)IBA 03/2006
1	Protons (Proton)IBA 10/2002

Therapy/Procedure

3	Electrodes (Electrode) 01/2019 - 10/2002
1	Craniotomy 02/2017
1	Split-Brain Procedure (Split-Brain) 01/2016
1	Therapeutics 08/2015